scispace - formally typeset
E

Eric S. Kilpatrick

Researcher at Hull Royal Infirmary

Publications -  142
Citations -  6950

Eric S. Kilpatrick is an academic researcher from Hull Royal Infirmary. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 42, co-authored 132 publications receiving 6417 citations. Previous affiliations of Eric S. Kilpatrick include Hull York Medical School & Hull and East Yorkshire Hospitals NHS Trust.

Papers
More filters
Journal ArticleDOI

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes: response to the International Expert Committee.

TL;DR: Members of the International Expert Committee have recommended that diabetes should be diagnosed if A1C is ≤6.5%, without need to measure the plasma glucose concentration, but there are concerns that practical limitations will lead to false positives and negatives with this approach.
Journal ArticleDOI

Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes : Double diabetes in the diabetes control and complications trial

TL;DR: Higher insulin resistance at baseline in the DCCT (as estimated by eGDR) was associated with increased subsequent risk of both micro- and macrovascular complications, and insulin dose and the presence of IDF-defined metabolic syndrome were poor predictors by comparison.
Journal ArticleDOI

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial

TL;DR: In this article, the effect of HbA1c variability on the risk of retinopathy and nephropathy in patients with type 1 diabetes was analyzed using multivariate Cox regression.
Journal ArticleDOI

The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes

TL;DR: In this article, the effect of glucose variability on the risk of retinopathy and nephropathy in patients with type 1 diabetes was analyzed using multivariate Cox regression, and it was shown that within-day and between-day variability in blood glucose around a patient's mean value has no influence on the development or progression of either retinopathies (P = 0.18 and P =0.72, respectively) or nephropharmasy (P < 0.57).
Journal ArticleDOI

Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes.

TL;DR: Results show that dietary supplementation with soy phytoestrogens favorably alters insulin resistance, glycemic control, and serum lipoproteins in postmenopausal women with type 2 diabetes, thereby improving their cardiovascular risk profile.